首页> 外文期刊>Nature >Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
【24h】

Enhanced proofreading governs CRISPR-Cas9 targeting accuracy

机译:增强的校对决定CRISPR-Cas9的靶向准确性

获取原文
获取原文并翻译 | 示例
       

摘要

The RNA-guided CRISPR-Cas9 nuclease from Streptococcus pyogenes (SpCas9) has been widely repurposed for genome editing1-4. High-fidelity (SpCas9-HF1) and enhanced specificity (eSpCas9(1.1)) variants exhibit substantially reduced off-target cleavage in human cells, but the mechanism of target discrimination and the potential to further improve fidelity are unknown5-9. Here, using single-molecule Frster resonance energy transfer experiments, we show that both SpCas9-HF1 and eSpCas9(1.1) are trapped in an inactive state10 when bound to mismatched targets. We find that a non-catalytic domain within Cas9, REC3, recognizes target complementarity and governs the HNH nuclease to regulate overall catalytic competence. Exploiting this observation, we design a new hyper-accurate Cas9 variant (HypaCas9) that demonstrates high genome-wide specificity without compromising on-target activity in human cells. These results offer a more comprehensive model to rationalize and modify the balance between target recognition and nuclease activation for precision genome editing.
机译:化脓性链球菌(SpCas9)的RNA引导的CRISPR-Cas9核酸酶已被广泛用于基因组编辑1-4。高保真度(SpCas9-HF1)和增强的特异性(eSpCas9(1.1))变异体在人细胞中的脱靶切割显着减少,但靶标识别机制和进一步提高保真度的潜力尚不清楚5-9。在这里,使用单分子Frster共振能量转移实验,我们发现当SpCas9-HF1和eSpCas9(1.1)绑定到不匹配的靶标时,它们都处于非活动状态10。我们发现,Cas9,REC3中的一个非催化域识别目标互补性并控制HNH核酸酶来调节总体催化能力。利用这一观察结果,我们设计了一种新的超高精度Cas9变体(HypaCas9),该变体表现出高全基因组特异性,而不会损害人类细胞中的靶向活性。这些结果提供了一个更全面的模型来合理化和修改目标识别与核酸酶激活之间的平衡,以进行精确的基因组编辑。

著录项

  • 来源
    《Nature》 |2017年第7676期|407-410|共4页
  • 作者单位

    Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA;

    Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA;

    Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA|Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA|Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA;

    Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA|Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA;

    Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA|Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA;

    Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA;

    Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA|Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA;

    Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA|Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA|Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA;

    Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA|Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA;

    Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA|Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA|Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA|Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:51:55

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号